Neal Berger, MD
Orthopedic Surgery · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 4 carriers
- Offices
- 2
- Since medical school
- 17 years
- University of California, Davis School of Medicine, 2009
Offices
2 locations · Dignity Health Medical Foundation · 1,211 clinicians in this group
Hospitals listed: 053193 · 059517 · 059546 · 757893 · Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Berger’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A116874 · Current
Licensed to practise in California · since 2011 · expires 2027-02-28 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$388,938
Medicare paid this office $388,938 for 555 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 388 | $93,895 | $124 |
| Replacement of knee joint, both sides of knee | 44 | $54,914 | $1,220 |
| New patient visit (45+ min) | 181 | $29,708 | $164 |
| Replacement of thigh bone and hip joint with prosthesis | 22 | $29,571 | $1,232 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 60 | $28,881 | None |
See all 16 services
| Return visit (30+ min) | 388 | $93,895 | $124 |
| Replacement of knee joint, both sides of knee | 44 | $54,914 | $1,220 |
| New patient visit (45+ min) | 181 | $29,708 | $164 |
| Replacement of thigh bone and hip joint with prosthesis | 22 | $29,571 | $1,232 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 60 | $28,881 | None |
| Aspiration and/or injection of fluid from large joint | 181 | $28,879 | $72 |
| Long return visit (40+ min) | 97 | $21,128 | $173 |
| Anchoring of biceps tendon | 12 | $5,207 | $401 |
| New patient visit (60+ min) | 21 | $4,192 | $200 |
| New patient visit (30+ min) | 39 | $3,796 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,069 | $118 |
| Short return visit (20+ min) | 28 | $2,645 | $91 |
| Partial removal of knee joint lining using an endoscope | 12 | $1,425 | $119 |
| Aspiration and/or injection of fluid from medium joint | 12 | $764 | $64 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 122 | $556 | None |
| Injection, methylprednisolone acetate, 1 mg | 33 | $122 | None |
Procedures Medicare counted
| Hip replacement | 32 | More than 78% of doctors who do this |
| Knee replacement | 38 | More than 71% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 28 | More than 96% of doctors who do this |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 52 | More than 87% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 262 | 247 | 279 | 291 | 389 | 400 |
| Replacement of knee joint, both sides of knee | 18 | – | 14 | 19 | 36 | 45 |
| Replacement of thigh bone and hip joint with prosthesis | 17 | 18 | 22 | 22 | 25 | 24 |
| Anchoring of biceps tendon | – | – | 23 | 17 | 11 | 13 |
| Aspiration and/or injection of fluid from medium joint | – | – | – | – | 13 | 12 |
| Prosthetic repair of shoulder joint, total shoulder | – | – | 12 | – | 11 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
555 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 20% · Women 65% · Also on Medicaid 5% · Health risk score 1.04. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 72% · Coronary heart disease 26% · Diabetes 25% · Atrial fibrillation 20% · Chronic kidney disease 19% · Depression 15% · Cancer 14% · Heart failure 13% · COPD 11% · Dementia 7% · Stroke 6%.
The office billed $1,618,795, Medicare allowed $493,099 and paid $388,938; for 4,157 services of 65 kinds; $29,615 of it was for drugs given in the office and $359,323 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 555 | 4,157 | 77 | 1.04 | $1,618,795 | $388,938 |
| 2023 | 520 | 2,676 | 77 | 1.02 | $1,503,326 | $349,416 |
| 2022 | 425 | 2,145 | 78 | 1.11 | $1,275,391 | $297,251 |
| 2021 | 394 | 1,993 | 77 | 1.01 | $1,201,864 | $273,161 |
| 2020 | 326 | 1,541 | 77 | 1.20 | $848,999 | $194,298 |
| 2019 | 325 | 1,615 | 76 | 0.95 | $712,971 | $198,209 |
| 2018 | 402 | 2,293 | 75 | 0.90 | $976,779 | $228,460 |
| 2017 | 356 | 2,253 | 75 | 1.04 | $737,603 | $183,633 |
| 2016 | 261 | 1,811 | 74 | 0.90 | $541,261 | $150,501 |
| 2015 | 75 | 370 | 73 | 0.82 | $109,690 | $28,100 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 306 | $65,359 | $119 |
| Replacement of knee joint, both sides of knee | 35 | $42,290 | $1,175 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 68 | $31,756 | None |
| Replacement of thigh bone and hip joint with prosthesis | 25 | $28,222 | $1,129 |
| Aspiration and/or injection of fluid from large joint | 160 | $27,016 | $69 |
| New patient visit (45+ min) | 114 | $17,783 | $156 |
| Long return visit (40+ min) | 73 | $15,382 | $167 |
| Prosthetic repair of shoulder joint, total shoulder | 11 | $14,636 | $1,331 |
| Short return visit (20+ min) | 133 | $13,269 | $84 |
| New patient visit (30+ min) | 105 | $11,108 | $106 |
| Anchoring of biceps tendon | 11 | $4,248 | $386 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 45 | $3,350 | $73 |
| Aspiration and/or injection of fluid from medium joint | 13 | $699 | $54 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 106 | $514 | None |
| Injection, methylprednisolone acetate, 40 mg | 36 | $313 | None |
2022: 14 services
| Return visit (30+ min) | 278 | $54,652 | $115 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 53 | $29,167 | None |
| Replacement of thigh bone and hip joint with prosthesis | 22 | $25,620 | $1,165 |
| Replacement of knee joint, both sides of knee | 18 | $21,978 | $1,157 |
| Aspiration and/or injection of fluid from large joint | 120 | $20,642 | $71 |
| New patient visit (45+ min) | 103 | $15,472 | $150 |
| Short return visit (20+ min) | 112 | $11,309 | $81 |
| New patient visit (30+ min) | 84 | $8,487 | $101 |
| Anchoring of biceps tendon | 16 | $6,261 | $368 |
| Long return visit (40+ min) | 30 | $5,303 | $166 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 33 | $2,932 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,890 | $118 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 82 | $406 | None |
| Injection, methylprednisolone acetate, 40 mg | 15 | $92 | None |
2021: 19 services
| Return visit (30+ min) | 262 | $53,719 | $114 |
| Replacement of thigh bone and hip joint with prosthesis | 21 | $25,977 | $1,181 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 47 | $24,382 | None |
| Aspiration and/or injection of fluid from large joint | 124 | $18,769 | $67 |
| Replacement of knee joint, both sides of knee | 14 | $16,616 | $1,187 |
| Prosthetic repair of shoulder joint, total shoulder | 12 | $16,089 | $1,341 |
| Repair of shoulder rotator cuff using an endoscope | 14 | $14,007 | $1,001 |
| New patient visit (45+ min) | 95 | $13,430 | $141 |
| Short return visit (20+ min) | 117 | $11,661 | $80 |
| Anchoring of biceps tendon | 22 | $8,827 | $384 |
| New patient visit (30+ min) | 52 | $5,204 | $100 |
| Long return visit (40+ min) | 23 | $5,164 | $172 |
| Partial removal of collar bone at shoulder using an endoscope | 11 | $2,123 | $193 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,087 | $123 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 13 | $2,029 | $156 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,355 | $90 |
| Limited removal of abnormal shoulder joint tissue using endoscope | 13 | $826 | $64 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 70 | $348 | None |
| Injection, methylprednisolone acetate, 40 mg | 38 | $210 | None |
2020: 11 services
| Return visit (30+ min) | 205 | $33,058 | $97 |
| Replacement of thigh bone and hip joint with prosthesis | 17 | $22,377 | $1,243 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 35 | $16,532 | None |
| Aspiration and/or injection of fluid from large joint | 100 | $13,236 | $54 |
| New patient visit (45+ min) | 94 | $13,190 | $140 |
| Short return visit (20+ min) | 69 | $5,613 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,415 | $122 |
| New patient visit (30+ min) | 32 | $2,979 | $93 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $1,502 | $88 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 65 | $387 | None |
| Injection, methylprednisolone acetate, 40 mg | 26 | $170 | None |
2019: 11 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 44 | $46,613 | None |
| Return visit (30+ min) | 175 | $26,356 | $98 |
| Replacement of knee joint, both sides of knee | 18 | $22,132 | $1,230 |
| Replacement of thigh bone and hip joint with prosthesis | 16 | $20,915 | $1,230 |
| Aspiration and/or injection of fluid from large joint | 102 | $13,298 | $51 |
| Short return visit (20+ min) | 126 | $12,776 | $66 |
| New patient visit (45+ min) | 77 | $10,778 | $140 |
| New patient visit (30+ min) | 62 | $6,116 | $99 |
| X-ray of knee, 4 or more views | 23 | $998 | $34 |
| X-ray of shoulder, minimum of 2 views | 14 | $487 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 68 | $406 | None |
2018: 17 services
| Replacement of knee joint, both sides of knee | 30 | $40,423 | $1,155 |
| Return visit (30+ min) | 231 | $32,475 | $90 |
| Replacement of thigh bone and hip joint with prosthesis | 25 | $30,059 | $1,156 |
| Short return visit (20+ min) | 187 | $19,642 | $60 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 39 | $17,819 | None |
| New patient visit (45+ min) | 116 | $16,100 | $139 |
| Aspiration and/or injection of fluid from large joint | 119 | $13,643 | $48 |
| New patient visit (30+ min) | 53 | $4,542 | $86 |
| X-ray of knee, 4 or more views | 71 | $3,271 | $36 |
| X-ray of hip, 2-3 views | 43 | $2,091 | $39 |
| Long return visit (40+ min) | 14 | $1,706 | $122 |
| X-ray of knee, 3 views | 28 | $1,266 | $30 |
| X-ray of pelvis, 1-2 views | 32 | $976 | $28 |
| X-ray of shoulder, minimum of 2 views | 23 | $751 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 102 | $564 | None |
| X-ray of hip, 1 view | 17 | $492 | $25 |
| X-ray of lower and sacral spine, 2-3 views | 12 | $366 | $30 |
2017: 15 services
| Short return visit (20+ min) | 227 | $29,609 | $61 |
| Replacement of knee joint, both sides of knee | 23 | $26,651 | $1,025 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 48 | $20,520 | None |
| Return visit (30+ min) | 122 | $15,844 | $91 |
| Aspiration and/or injection of fluid from large joint | 105 | $12,731 | $47 |
| New patient visit (30+ min) | 136 | $11,569 | $85 |
| X-ray of knee, 4 or more views | 59 | $3,172 | $36 |
| X-ray of hip, 2-3 views | 48 | $2,312 | $37 |
| X-ray of knee, 3 views | 36 | $1,610 | $32 |
| X-ray of pelvis, 1-2 views | 37 | $1,457 | $30 |
| X-ray of knee, 1-2 views | 17 | $893 | $30 |
| X-ray of shoulder, minimum of 2 views | 18 | $606 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 80 | $572 | None |
| X-ray of hip, 1 view | 20 | $545 | $27 |
| X-ray of lower and sacral spine, 2-3 views | 14 | $435 | $31 |
2016: 12 services
| Return visit (30+ min) | 150 | $23,086 | $95 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 44 | $21,223 | None |
| Short return visit (20+ min) | 137 | $18,824 | $62 |
| Replacement of knee joint, both sides of knee | 14 | $15,790 | $1,128 |
| Replacement of thigh bone and hip joint with prosthesis | 11 | $13,167 | $1,197 |
| Aspiration and/or injection of fluid from large joint | 94 | $12,247 | $48 |
| New patient visit (30+ min) | 77 | $6,799 | $88 |
| X-ray of knee, 4 or more views | 56 | $3,001 | $38 |
| X-ray of hip, 2-3 views | 34 | $1,820 | $39 |
| X-ray of knee, 3 views | 17 | $856 | $36 |
| X-ray of shoulder, minimum of 2 views | 19 | $800 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 68 | $484 | None |
2015: 4 services
| Short return visit (20+ min) | 53 | $5,113 | $68 |
| New patient visit (30+ min) | 25 | $2,547 | $102 |
| Aspiration and/or injection of fluid from large joint | 14 | $2,208 | $51 |
| X-ray of knee, 4 or more views | 14 | $604 | $40 |
Medicaid work
$2,629 in 2024
Medicaid paid $2,629 for 58 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 58 | $2,629 |
| 2024 | 58 | 1 | 16 | $2,629 |
| 2023 | 48 | 1 | 17 | $2,128 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 48 | $2,128 |
Drugs they prescribed that Part D paid
$233
Pharmacies billed $233 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
13 generic and 0 brand-name prescriptions · $233 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 13 | None | None | 0% | $233 |
| 2023 | 84 | 53 | 48% (40) | 0% | $1,184 |
| 2022 | 144 | 81 | 36% (52) | 0% | $1,328 |
| 2021 | 202 | 93 | 40% (81) | None | $7,230 |
| 2020 | 230 | 82 | 41% (95) | None | $2,550 |
| 2019 | 220 | 77 | 40% (87) | 5% | $2,848 |
| 2018 | 307 | 96 | 37% (114) | 5% | $5,080 |
| 2017 | 182 | 77 | 57% (104) | None | $2,093 |
| 2016 | 82 | 37 | 70% (57) | None | $1,640 |
| 2015 | 34 | 23 | 53% (18) | None | $547 |
| 2014 | 19 | 16 | 68% (13) | None | $599 |
| 2013 | 58 | 31 | 69% (40) | None | $1,413 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Tramadol | 21 | $118 | $6 |
2022: 7 drugs
| Celecoxib | 12 | $455 | $38 |
| Oxycodone-Acetaminophen | 17 | $190 | $11 |
| Diclofenac | 11 | $189 | $17 |
| Hydrocodone-Acetaminophen | 21 | $107 | $5 |
| Ondansetron | 13 | $101 | $8 |
| Meloxicam | 32 | $76 | $2 |
| Tramadol | 12 | $52 | $4 |
2021: 7 drugs
| Diclofenac | 18 | $384 | $21 |
| Oxycodone-Acetaminophen | 34 | $370 | $11 |
| Ondansetron | 21 | $216 | $10 |
| Meloxicam | 33 | $187 | $6 |
| Hydrocodone-Acetaminophen | 21 | $158 | $8 |
| Tramadol | 17 | $61 | $4 |
| Amoxicillin | 13 | $27 | $2 |
2020: 7 drugs
| Celecoxib | 15 | $536 | $36 |
| Oxycodone-Acetaminophen | 43 | $524 | $12 |
| Ondansetron | 28 | $238 | $9 |
| Meloxicam | 48 | $176 | $4 |
| Hydrocodone-Acetaminophen | 25 | $149 | $6 |
| Morphine Sulfate Er | 12 | $63 | $5 |
| Tramadol | 12 | $53 | $4 |
2019: 7 drugs
| Oxycodone-Acetaminophen | 40 | $667 | $17 |
| Enoxaparin | 11 | $497 | $45 |
| Meloxicam | 60 | $243 | $4 |
| Hydrocodone-Acetaminophen | 22 | $226 | $10 |
| Ondansetron | 18 | $141 | $8 |
| Morphine Sulfate Er | 14 | $116 | $8 |
| Amoxicillin | 13 | $80 | $6 |
2018: 9 drugs
| Oxycodone-Acetaminophen | 54 | $957 | $18 |
| Enoxaparin | 13 | $866 | $67 |
| Ondansetron Odt | 36 | $443 | $12 |
| Meloxicam | 47 | $202 | $4 |
| Morphine Sulfate Er | 27 | $189 | $7 |
| Pantoprazole | 37 | $138 | $4 |
| Hydrocodone-Acetaminophen | 12 | $136 | $11 |
| Amoxicillin | 25 | $72 | $3 |
| Tramadol | 11 | $46 | $4 |
2017: 4 drugs
| Oxycodone-Acetaminophen | 56 | $774 | $14 |
| Hydrocodone-Acetaminophen | 20 | $112 | $6 |
| Meloxicam | 30 | $98 | $3 |
| Tramadol | 16 | $65 | $4 |
2016: 1 drug
| Oxycodone-Acetaminophen | 28 | $513 | $18 |
2015: 1 drug
| Oxycodone-Acetaminophen | 11 | $293 | $27 |
2013: 2 drugs
| Oxycodone | 11 | $177 | $16 |
| Hydrocodone-Acetaminophen | 12 | $173 | $14 |
Money from drug and device companies
$84 in 2025
| 2025 | 1 | 1 | None | $84 |
| 2021 | 4 | 14 | None | $1,585 |
| 2020 | 1 | 1 | None | $30 |
| 2019 | 3 | 20 | None | $2,583 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heron Therapeutics | Zynrelef | $84 | 1 payment
|
See the published payment
| Heron Therapeutics | Meals · 2025-01-14 | Zynrelef | $84 |
See earlier years (2021, 2020, 2019)
2021: $1,585
| Stryker | Mako | $1,115 | 7 payments
|
| Zimmer Biomet Holdings | Comprehensive Anatomic | $329 | 5 payments
|
| DePuy Synthes Sales | Velys | $109 | 1 payment
|
| Boston Scientific | Ilab | $32 | 1 payment
|
2020: $30
| Zimmer Biomet Holdings | Persona Revision | $30 | 1 payment
|
2019: $2,583
| Zimmer Biomet Holdings | Comprehensive Reverse | $2,558 | 18 payments
|
| Smith+Nephew | Novostitch | $14 | 1 payment
|
| DePuy Synthes Sales | Orthovisc | $11 | 1 payment
|
Checkups this office reported
1 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS)As Medicare defines this measure | 0% | None |
Professional record
- NPI
- 1295071876
- Licence
- CA A116874California A116874: Current · expires 2027-02-28
- Trained
- University of California, Davis School of Medicine, 2009 · 17 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 3400 Data Dr, Attn: Credentialing/Payer Enrollment, Rancho Cordova, CA, 95670
- NPI first listed
- 2012-12-30
- NPI last updated
- 2019-05-10
This is when the NPI record was last certified, not a medical board exam.